ATLANTA – The National Marrow Donor Program (NMDP), the federally funded organization that facilitates most matched unrelated donor transplants in the United States, has released outcome data that indicate Northside Hospital’s Blood and Marrow Transplant (BMT) Program has, by far, the best survival rates for matched related and unrelated transplants of any program in the country. The most recently released outcome data was based on related transplants performed Jan. 1, 2008 to Dec. 31, 2008, and unrelated transplants performed Jan. 1, 2004 to Dec. 31, 2008, with 100-day follow-up post transplant. Rankings are among BMT programs that performed more than two transplants during the research period.
Transplanting healthy marrow may be the best and only hope of a cure for life-threatening diseases such as leukemia, lymphoma and other blood disorders. The BMT program at Northside is one of the largest and most comprehensive programs in the nation, serving patients who require bone marrow or stem cell transplants. Patients don’t need to travel far to have access to the full range of available hematopoietic transplants, including those from matched related, matched unrelated and haploidentical donors and cord blood transplants. All services are conveniently located at Northside’s Atlanta campus.
In 2010, 175 transplants were performed at Northside, placing the hospital among the top 10 percent of all BMT programs in the nation in terms of volume. The one-year survival of matched unrelated donor patients transplanted at Northside was 77 percent, the best of any BMT program in the country. Furthermore, the actual survival was 19 percent above the survival expected by the NMDP for Northside, based on the risk profile of the patients transplanted (56.3 percent). This is the greatest positive variance between expected and actual survival for any BMT program in the nation.
“Although transplant volume is important, our philosophy at Northside is focused on providing the most patient-friendly experience and the best clinical outcomes for patients undergoing BMT,” said H. Kent Holland, M.D., medical director of the BMT program at Northside Hospital. “The compassionate and state-of-the-art care provided surpasses that of many of the country’s most prestigious, academically oriented programs.”
In 2010, Northside also was selected to join the National Cancer Institute Community Cancer Centers Program (NCCCP), an exclusive group of 30 community cancer centers. Northside is the only hospital in Atlanta and one of only three hospitals in the southeastern United Stated chosen for this prestigious honor.”The BMT program’s high level of expertise in blood and marrow transplant therapy and strong portfolio of clinical research play an integral role in Northside’s award from the NCCCP,” said Bob Quattrocchi, president and CEO of Northside Hospital. “We are extremely proud of the commitment to quality of the more than 200 professionals that work in our BMT program.”
An accomplished group of nationally recognized physicians, along with a team of highly trained professionals, spearhead the amazing work that takes place in Northside’s newly renovated inpatient and outpatient BMT units, laboratory and blood donor center. Together, they provide patients with promising hope for a disease-free existence.
For more information about the Blood and Marrow Transplant Program at Northside Hospital, visit www.northside.com and www.BMTGA.com. For more information about the National Marrow Donor program, visit www.nmdp.org or www.BeTheMatch.org.